ANI PHARMACEUTICALS, INC (ANIP) Market Cap
- 2025-12-31: Market Cap $1.78B.
- 2024-12-31: Market Cap $1.17B.
- 2013-02-28: Market Cap $191.96M.
- 2012-07-31: Market Cap $194.66M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2012-03-12 to 2025-12-31
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2025-12-31 | $1.78B |
| 2024-12-31 | $1.17B |
| 2013-02-28 | $191.96M |
| 2012-07-31 | $194.66M |
| 2012-03-12 | $3.22B |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |